Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Neoplasms × Sorafenib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 16 Leukemia, Myeloid, Acute 7 Neoplasms 4 Liver Neoplasms 4 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Fibrolamellar hepatocellular carcinoma 2 Tongue Neoplasms 1 Thyroid cancer, Hurthle cell 1 Thyroid Diseases 1 Sarcoma, Myeloid 1 Salivary Gland Neoplasms 1 Rhabdomyosarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors 1 Melanoma 1 Hepatoblastoma 1 Gastrointestinal Stromal Tumors 1 Desmoplastic Small Round Cell Tumor 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma 1 Brain Neoplasms 1

Interventions

Bevacizumab 104 Fluorouracil 84 Leucovorin 76 Oxaliplatin 71 Cetuximab 71 Irinotecan 62 pembrolizumab 60 Capecitabine 39 Nivolumab 38 Specimen Handling 34 regorafenib 29 Folfox protocol 26 Panitumumab 24 Magnetic Resonance Spectroscopy 22 Biopsy 22 trifluridine tipiracil drug combination 21 IFL protocol 21 Standard of Care 19 HMPL-013 19 tislelizumab 18 atezolizumab 18 Cisplatin 18 Carboplatin 18 Blood Specimen Collection 18 Gemcitabine 17 Colonoscopy 15 Trifluridine 14 Paclitaxel 13 Ipilimumab 13 Interviews as Topic 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00989469 2026-02-05

NEXIRI

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡